FDA Approves Eli Lilly’s GLP-1 Weight Loss Pill Foundayo, Igniting a New Battle in the Obesity Market
FDA approves Eli Lilly’s GLP-1 weight loss pill Foundayo. A once-daily oral drug that could transform obesity care. Read analysis.
FDA approves Eli Lilly’s GLP-1 weight loss pill Foundayo. A once-daily oral drug that could transform obesity care. Read analysis.